nicergoline has been researched along with Memory Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Battaglia, A; Battaglia, G; Bosco, P; Calafiore, M; Canonico, PL; Caraci, F; Chisari, M; Copani, A; Frasca, G; Nicoletti, F; Sortino, MA | 1 |
Rakhmankulova, IKh; Voronina, TA | 1 |
2 other study(ies) available for nicergoline and Memory Disorders
Article | Year |
---|---|
Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Astrocytes; bcl-2-Associated X Protein; Cell Communication; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Cognition Disorders; Memory Disorders; Nerve Growth Factors; Neurons; Neuroprotective Agents; Nicergoline; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley | 2005 |
[Pharmacological analysis of memory disorders of different origins].
Topics: Amnesia; Animals; Anti-Anxiety Agents; Avoidance Learning; Benzodiazepines; Benzodiazepinones; Conditioning, Classical; Drug Evaluation, Preclinical; Electroshock; Male; Meclofenoxate; Memory Disorders; Mice; Nicergoline; Piracetam; Psychotropic Drugs; Reaction Time; Scopolamine; Structure-Activity Relationship | 1989 |